Red Fluorescent Silica Nanoparticles

Product Overview
Red fluorescent silica nanoparticles are silica-based nanomaterials with red fluorescence properties. These particles are typically prepared using the sol-gel method, and feature tunable porous structures and abundant surface functional groups. The material has broad applications in various fields, including biomedicine, catalysis, environmental protection, and optics. Surface modifications further enhance the functionality of silica nanoparticles, expanding their potential applications.

Key Features

• High Surface Area:Provides numerous active sites, enhancing interactions with other substances. This allows for more efficient catalyst loading in catalytic reactions.
• Ordered Mesoporous Structure:The uniform and tunable pore size is ideal for substance transport and diffusion. In drug delivery, it allows for controlled release of therapeutic molecules.
• Good Thermal and Chemical Stability:Maintains structural and functional stability under high temperature and various chemical environments.
• Strong Surface Modifiability:The surface can be easily functionalized through chemical methods, making it adaptable to different application needs.
• Good Biocompatibility:Exhibits low toxicity to biological systems, making it suitable for use in biomedicine with high safety.

Applications

• Drug Delivery:Drugs can be loaded into the mesoporous silica pores, and thanks to the slow release characteristics, surface modifications can enable targeted therapy, enhancing effectiveness while minimizing damage to healthy cells.
• Biological Imaging:Loaded with fluorescent molecules (such as FITC, Cy5.5) or magnetic nanoparticles, these particles are used for cell and in vivo imaging, allowing for real-time monitoring of biological processes.
• Gene Therapy:Acts as a gene delivery vector, protecting gene stability and improving transfer efficiency in vivo.
• Diagnostic Reagents:Used for biomarker detection by loading molecules that recognize disease-related biomarkers, enabling early-stage diagnosis of diseases.